7 Einträge gefunden

1. Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program

   1. Müller, V
   2. Banys-Paluchowski, M
   3. Friedl, T W P
   4. Fasching, P A
   5. Schneeweiss, A
   6. Hartkopf, A
   7. Wallwiener, D

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

   1. Karn, T
   2. Denkert, C
   3. Weber, K E
   4. Holtrich, U
   5. Hanusch, C
   6. Sinn, B V
   7. Higgs, B W

   2020 - Forschungsinformationssystem des UKE
3. Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer

   1. Villegas, S L
   2. Darb-Esfahani, S
   3. von Minckwitz, G
   4. Huober, J
   5. Weber, K
   6. Marmé, F
   7. Furlanetto, J

   2018 - Forschungsinformationssystem des UKE
4. Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial

   1. Möbus, V
   2. Jackisch, C
   3. Lück, H J
   4. du Bois, A
   5. Thomssen, C
   6. Kuhn, W
   7. Nitz, U

   2018 - Forschungsinformationssystem des UKE
5. German Adjuvant Intergroup Node-positive Study (GAIN):a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients

   1. Möbus, V
   2. von Minckwitz, G
   3. Jackisch, C
   4. Lück, H-J
   5. Schneeweiss, A
   6. Tesch, H
   7. Elling, D

   2017 - Forschungsinformationssystem des UKE
6. Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy

   1. Lindner, J L
   2. Loibl, S
   3. Denkert, C
   4. Ataseven, B
   5. Fasching, P A
   6. Pfitzner, B M
   7. Gerber, B

   2015 - Forschungsinformationssystem des UKE
7. Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine.

   1. Reichmann, U
   2. Bokemeyer, Carsten
   3. Wallwiener, D
   4. Bamberg, M
   5. Huober, J

   2007 - Forschungsinformationssystem des UKE